×




Biopure Corp. Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Biopure Corp. case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Biopure Corp. case study is a Harvard Business School (HBR) case study written by John T. Gourville. The Biopure Corp. (referred as “Biopure Oxyglobin” from here on) case study provides evaluation & decision scenario in field of Sales & Marketing. It also touches upon business topics such as - Value proposition, Pricing.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Biopure Corp. Case Study


It is early 1998 and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten-year history, has just received government approval to release Oxyglobin, a revolutionary new "blood substitute" designed to replace the need for donated animal blood in the veterinary market. A virtually identical product for the human market, Hemopure, is in the final stages of testing by Biopure and is expected to gain approval within one to two years. In response to the timing of approval for these two products, there has been a long-running debate within Biopure as how to proceed with Oxyglobin. At odds are those in charge of Oxyglobin, who want to see the animal product released immediately, and those in charge of the Hemopure, who worry that an immediate release of Oxyglobin would create an unrealistically low price expectation for what they feel should be a very high-margin human product. Exacerbating the problem is the nature of the biopharmaceutical industry, where product approval is never a certainty until achieved.


Case Authors : John T. Gourville

Topic : Sales & Marketing

Related Areas : Pricing




Calculating Net Present Value (NPV) at 6% for Biopure Corp. Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10002643) -10002643 - -
Year 1 3454448 -6548195 3454448 0.9434 3258913
Year 2 3964497 -2583698 7418945 0.89 3528388
Year 3 3950181 1366483 11369126 0.8396 3316648
Year 4 3226708 4593191 14595834 0.7921 2555855
TOTAL 14595834 12659805




The Net Present Value at 6% discount rate is 2657162

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Internal Rate of Return
2. Profitability Index
3. Net Present Value
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Biopure Oxyglobin have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Biopure Oxyglobin shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Biopure Corp.

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Sales & Marketing Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Biopure Oxyglobin often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Biopure Oxyglobin needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10002643) -10002643 - -
Year 1 3454448 -6548195 3454448 0.8696 3003868
Year 2 3964497 -2583698 7418945 0.7561 2997729
Year 3 3950181 1366483 11369126 0.6575 2597308
Year 4 3226708 4593191 14595834 0.5718 1844881
TOTAL 10443786


The Net NPV after 4 years is 441143

(10443786 - 10002643 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10002643) -10002643 - -
Year 1 3454448 -6548195 3454448 0.8333 2878707
Year 2 3964497 -2583698 7418945 0.6944 2753123
Year 3 3950181 1366483 11369126 0.5787 2285984
Year 4 3226708 4593191 14595834 0.4823 1556090
TOTAL 9473904


The Net NPV after 4 years is -528739

At 20% discount rate the NPV is negative (9473904 - 10002643 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Biopure Oxyglobin to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Biopure Oxyglobin has a NPV value higher than Zero then finance managers at Biopure Oxyglobin can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Biopure Oxyglobin, then the stock price of the Biopure Oxyglobin should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Biopure Oxyglobin should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

Understanding of risks involved in the project.

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

What can impact the cash flow of the project.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Biopure Corp.

References & Further Readings

John T. Gourville (2018), "Biopure Corp. Harvard Business Review Case Study. Published by HBR Publications.


QPL Intl SWOT Analysis / TOWS Matrix

Technology , Semiconductors


Medco Energi SWOT Analysis / TOWS Matrix

Energy , Oil & Gas Operations


Sumitomo Electric Industries SWOT Analysis / TOWS Matrix

Consumer Cyclical , Auto & Truck Parts


Zhejiang Commodities SWOT Analysis / TOWS Matrix

Services , Retail (Department & Discount)


COFCO Meat SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Rheon Automatic Machinery SWOT Analysis / TOWS Matrix

Consumer/Non-Cyclical , Food Processing


Camurus AB SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


ADMA Biologics Inc SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Centerra Gold SWOT Analysis / TOWS Matrix

Basic Materials , Gold & Silver